Techstars global leaders share innovative best practices and insights at Nextrise 2022 SEOUL, South Korea--(BUSINESS WIRE)--#startups--Techstars, a global investment business…
Doubling of median overall survival seen in QuANTUM-First results presented at EHA Presidential Symposium Data support potential of quizartinib as…
Rapid and potent C5 inhibition achieved with complete and sustained blockage of complement by a single dose of CAN106 Data…
DUBLIN--(BUSINESS WIRE)--The "Global Ammunition Market 2021-2027" report has been added to ResearchAndMarkets.com's offering. The global ammunition market is projected to…
ULAANBAATAR, Mongolia--(BUSINESS WIRE)--Munkhjin Otgonbaatar, co-founder and COO of Ih Bit Global, revealed that IHC will be listed on KuCoin on…
DUBLIN--(BUSINESS WIRE)--The "India Self Testing Kits Market By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine…
DUBLIN--(BUSINESS WIRE)--The "India Self Testing Kits Market By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine…
HERZOGENAURACH, Germany--(BUSINESS WIRE)--Three-time MMA world champion and PUMA Ambassador Joanna J?drzejczyk shares her vision of mixed martial arts, as…
HERZOGENAURACH, Germany--(BUSINESS WIRE)--Three-time MMA world champion and PUMA Ambassador Joanna J?drzejczyk shares her vision of mixed martial arts, as…
We are also excited to release the key art ahead of its release! OSAKA, Japan--(BUSINESS WIRE)--#ObeyMe--“Obey Me!” — a mobile…
We are also excited to release the key art ahead of its release! OSAKA, Japan--(BUSINESS WIRE)--#ObeyMe--“Obey Me!” — a mobile…
Partnership to effectively promote large-scale commercialization and in-depth integration of the industry ecosystem SHENZHEN, China--(BUSINESS WIRE)--#RoboSense--RoboSense, a world-leading provider of…
-- Breakthrough Therapy Designations granted for ROS1-positive non-small cell lung cancer (NSCLC) patients pretreated with one prior line of ROS1…
Clinical data and patient-reported outcomes across extensive clinical development program for zanubrutinib (BRUKINSA®) reinforce its potential across B-cell malignancies Long-term…
Tislelizumab is now approved in nine indications in China CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING--(BUSINESS WIRE)--$BGNE #BTKi--BeiGene (NASDAQ: BGNE; HKEX:…